From: (Correcting) misdiagnoses of asthma: a cost effectiveness analysis
Characteristics | Per 100 Patients screened |
---|---|
% Not Asthmatic | 28 |
   2.5% Credible Interval | 19 |
   97.5% Credible Interval | 37 |
% Not Asthmatic and on Daily Medication | 20 |
   2.5% Credible Interval | 13 |
   97.5% Credible Interval | 28 |
Average Cost Savings | $35,141 |
   2.5% Credible Interval | $4,588 |
   97.5% Credible Interval | $69,278 |
*Average cost saving per patient screened is $ 351 | Â |
Sensitivity Analysis | Â |
25 year time horizon | Â |
Average Cost Savings | $24,390 |
   2.5% Credible Interval | $1,181 |
   97.5% Credible Interval | $47,600 |
*Average cost saving per patient screened is $ 243 | Â |
GP consult rather than specialist | Â |
Average Cost Savings | $45,016 |
   2.5% Credible Interval | $14,463 |
   97.5% Credible Interval | $79,153 |
*Average cost saving per patient screened is $ 450 | Â |
As needed 1 to 2 puffs of short-acting bronchodilator per week | Â |
Average Cost Savings | $29,798 |
   2.5% Credible Interval | -$3,396 |
   97.5% Credible Interval | $102,307 |
*Average cost saving per patient screened is $ 298 | Â |
As needed 4 to 8 puffs of short-acting bronchodilator per week | Â |
Average Cost Savings | $41,606 |
   2.5% Credible Interval | $474 |
   97.5% Credible Interval | $113,843 |
*Average cost saving per patient screened is $ 416 | Â |